Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated May 10th, 2019

An Oral Medicine for People With Relapsed CLL: Idelalisib

NOW
PLAYING
Families Heartbroken After Clinical Trial Studying Drug To Help Children With Rare Genetic Disorder Is Canceled
NOW
PLAYING
Choosing the Best Treatment Path in the Relapsed/ Refractory Multiple Myeloma Setting
NOW
PLAYING
Where Does Blenrep Fit in Multiple Myeloma Treatment Paradigm for Relapse? Excitement Over 48% Reduction in Disease Progression
NOW
PLAYING
Promising Data on Drug Nubeqa Could Mean Better Targeted Treatments for Men With Advanced Prostate Cancer
NOW
PLAYING
Balversa's FDA Approval Means a New, Practice-Changing Option for FGFR-Positive Bladder Cancer
NOW
PLAYING
A Powerful Tool: Integrating Venetoclax into CLL Management Improves Survival

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... chronic lymphocytic leukemia trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider